Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part II
- 30 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (5) , 626-630
- https://doi.org/10.1161/01.cir.0000021408.40925.63
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Medical economics and the assessment of value in cardiovascular medicine: Part I.Circulation, 2002
- Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trialsBMJ, 2000
- Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic statusJournal of the American College of Cardiology, 2000
- Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trialJournal of the American College of Cardiology, 2000
- Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplastyAmerican Heart Journal, 1999
- Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trialThe Lancet, 1997
- Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgeryThe Lancet, 1995
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists CollaborationPublished by Elsevier ,1994
- Myocardial Revascularization for Chronic Stable AnginaAnnals of Internal Medicine, 1990